This Article Full Text Full Text (PDF) All Versions of this Article: 138/1/9    most recent REP-09-0060v2 REP-09-0060v1 Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (1) Citing Articles via Google Scholar Google Scholar Articles by Cartwright, J. Articles by Horne, A. W Search for Related Content PubMed PubMed Citation Articles by Cartwright, J. Articles by Horne, A. W

Serum biomarkers of tubal ectopic pregnancy: current candidates and future possibilities

Division of Reproductive and Developmental Sciences, Simpson Centre for Reproductive Health, The University of Edinburgh, Royal Infirmary of Edinburgh, 51 Little France Crescent, Edinburgh EH16 4SB, UK

Correspondence should be addressed to A W Horne; Email: andrew.horne{at}ed.ac.uk

Ectopic pregnancy remains a considerable cause of maternal morbidity and mortality worldwide. Currently, it is diagnosed using a combination of transvaginal ultrasound and serial serum β-human chorionic gonadotrophin levels. Diagnosis is often delayed and these tests are time-consuming and costly, both psychologically to the patient and financially to health services. The development of a biomarker that can differentiate a tubal ectopic from an intrauterine implantation is therefore important. In the pre-genomic era, a one-by-one scientific approach has revealed over 20 candidate biomarkers that could be used as a test to diagnose ectopic pregnancy although at present their clinical utility is very limited. These biomarkers cluster into themes: markers of abnormal embryo/trophoblast growth, markers of abnormal corpus luteum function, markers of a growing pregnancy in the Fallopian tube, markers of inflammation and peritoneal irritation, and uterine markers of normal implantation. It is likely that this thematic approach will facilitate the identification of newer biomarkers using microarray technology and inform the development of investigative paradigms using multiple markers at the time of presentation.

This article has been cited by other articles:

				C.J. Wedderburn, P. Warner, B. Graham, W.C. Duncan, H.O.D. Critchley, and A.W. Horne Economic evaluation of diagnosing and excluding ectopic pregnancy Hum. Reprod., February 1, 2010; 25(2): 328 - 333. [Abstract] [Full Text] [PDF]